These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
3. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma]. Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369 [TBL] [Abstract][Full Text] [Related]
4. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840 [TBL] [Abstract][Full Text] [Related]
5. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513 [TBL] [Abstract][Full Text] [Related]
6. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases. Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308 [TBL] [Abstract][Full Text] [Related]
7. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers. Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414 [TBL] [Abstract][Full Text] [Related]
8. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789 [TBL] [Abstract][Full Text] [Related]
9. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
10. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report. Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320 [TBL] [Abstract][Full Text] [Related]
11. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hilgard P; Hamami M; Fouly AE; Scherag A; Müller S; Ertle J; Heusner T; Cicinnati VR; Paul A; Bockisch A; Gerken G; Antoch G Hepatology; 2010 Nov; 52(5):1741-9. PubMed ID: 21038413 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S; J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review. Salem R; Hunter RD Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S83-8. PubMed ID: 16979447 [TBL] [Abstract][Full Text] [Related]
14. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432. Ho S; Lau WY; Leung WT Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473 [No Abstract] [Full Text] [Related]
15. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Riaz A; Lewandowski RJ; Kulik L; Salem R Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310 [TBL] [Abstract][Full Text] [Related]
16. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504 [TBL] [Abstract][Full Text] [Related]
17. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920 [TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma. Allison C Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141 [TBL] [Abstract][Full Text] [Related]
19. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574 [TBL] [Abstract][Full Text] [Related]
20. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. Wang EA; Stein JP; Bellavia RJ; Broadwell SR Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]